Literature DB >> 8724568

MR imaging of pulmonary hypertension and right ventricular dysfunction.

L M Boxt1.   

Abstract

Right ventricular cardiac function is altered by abnormalities affecting primarily the left-sided cardiac structures, the lungs, or the right-sided cardiac structures themselves. The most common cardiac causes for right ventricular dysfunction are chronic left ventricular ischemia and rheumatic mitral valvular disease. Pulmonary diseases that result in right ventricular dysfunction include pulmonary air-space disease, including emphysema, and pulmonary interstitial and parenchymal diseases, including idiopathic pulmonary fibrosis and cystic fibrosis. Chronic pulmonary vascular disease, including chronic thromboembolism and PPH have a significant effect on right ventricular performance. Common to all of these diseases is elevation of pulmonary vascular resistance with a commensurate increase in right ventricular pressure, resulting in right ventricular hypertrophy. The limited ability of right ventricular myocardium to function in the face of increased pulmonary resistance results in right ventricular dilatation, tricuspid regurgitation, and ultimately right ventricular failure. MR imaging provides direct, noninvasive visualization of the right ventricular chamber as well as the myocardium itself, allowing reliable demonstration of morphologic changes in the size and shape of the ventricle, thickness of the myocardium, and presence of abnormal infiltration by fat or edema. Furthermore, because MR imaging techniques do not depend upon geometric assumptions about the complex shape of the right ventricle, they may be used for accurate and reproducible quantitation of right ventricular volume and myocardial mass.

Entities:  

Mesh:

Year:  1996        PMID: 8724568

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  6 in total

Review 1.  The role of 1.5T cardiac MRI in the diagnosis, prognosis and management of pulmonary arterial hypertension.

Authors:  Gianluca Marrone; Giuseppe Mamone; Angelo Luca; Patrizio Vitulo; Alessandro Bertani; Michele Pilato; Bruno Gridelli
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-25       Impact factor: 2.357

2.  Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension.

Authors:  Sebastian Ley; Derliz Mereles; Michael Puderbach; Ekkehard Gruenig; Helena Schöck; Monika Eichinger; Julia Ley-Zaporozhan; Christian Fink; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2007-01-16       Impact factor: 5.315

3.  Left Atrial Volume and Pulmonary Artery Diameter Are Noninvasive Measures of Age-Related Diastolic Dysfunction in Mice.

Authors:  Guillermo Medrano; Jesus Hermosillo-Rodriguez; Thuy Pham; Alejandro Granillo; Craig J Hartley; Anilkumar Reddy; Patricia Mejia Osuna; Mark L Entman; George E Taffet
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-10-28       Impact factor: 6.053

4.  Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phase-contrast MRI.

Authors:  Sebastian Ley; Michael Puderbach; Christian Fink; Monika Eichinger; Christian Plathow; Susanne Teiner; Matthias Wiebel; Frank-Michael Müller; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2005-03-11       Impact factor: 5.315

5.  Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension.

Authors:  Dalia Urboniene; Idith Haber; Yong-Hu Fang; Thenappan Thenappan; Stephen L Archer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-25       Impact factor: 5.464

Review 6.  Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis.

Authors:  Jon T Giles; Verônica Fernandes; Joao A C Lima; Joan M Bathon
Journal:  Arthritis Res Ther       Date:  2005-08-24       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.